ES2103928T5 - Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis. - Google Patents
Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.Info
- Publication number
- ES2103928T5 ES2103928T5 ES92903939T ES92903939T ES2103928T5 ES 2103928 T5 ES2103928 T5 ES 2103928T5 ES 92903939 T ES92903939 T ES 92903939T ES 92903939 T ES92903939 T ES 92903939T ES 2103928 T5 ES2103928 T5 ES 2103928T5
- Authority
- ES
- Spain
- Prior art keywords
- nucleic acids
- diagnosis
- polipeptides
- codify
- mycobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 201000008827 tuberculosis Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 241000186359 Mycobacterium Species 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Abstract
LA INVENCION SE REFIERE A ACIDOS NUCLEICOS QUE CONTIENEN PARTICULARMENTE UNA SECUENCIA NUCLEOTIDA QUE SE EXTIENDE DESDE EL EXTREMO CONSTITUIDA POR EL NUCLEOTIDO EN POSICION (1) AL EXTREMO CONSTITUIDO POR EL NUCLEOTIDO EN LA POSICION (1211) REPRESENTADA EN LA FIGURA, A LOS POLIPEPTIDOS CODIFICADOS POR DICHOS ACIDOS NUCLEICOS. LOS POLIPEPTIDOS DE LA INVENCION PUEDEN SER USADOS PARA EL DIAGNOSTICO DE LA TUBERCULOSIS, Y PUEDE TAMBIEN SER PARTE DEL PRINCIPIO ACTIVO EN LA PREPARACION DE UNA VACUNA CONTRA LA TUBERCULOSIS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91400388A EP0499003A1 (en) | 1991-02-14 | 1991-02-14 | Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2103928T3 ES2103928T3 (es) | 1997-10-01 |
ES2103928T5 true ES2103928T5 (es) | 2005-09-01 |
Family
ID=8208544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92903939T Expired - Lifetime ES2103928T5 (es) | 1991-02-14 | 1992-02-07 | Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis. |
Country Status (12)
Country | Link |
---|---|
US (2) | US5955356A (es) |
EP (2) | EP0499003A1 (es) |
JP (1) | JPH06504909A (es) |
AT (1) | ATE153697T1 (es) |
AU (1) | AU659822B2 (es) |
CA (1) | CA2104111C (es) |
DE (1) | DE69220042T3 (es) |
DK (1) | DK0571420T4 (es) |
ES (1) | ES2103928T5 (es) |
GR (1) | GR3024408T3 (es) |
IL (1) | IL100938A0 (es) |
WO (1) | WO1992014823A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK79793D0 (da) * | 1993-07-02 | 1993-07-02 | Statens Seruminstitut | Diagnostic test |
US6991797B2 (en) | 1993-07-02 | 2006-01-31 | Statens Serum Institut | M. tuberculosis antigens |
US7300660B2 (en) | 1993-11-23 | 2007-11-27 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
DE69435138D1 (de) | 1993-11-23 | 2008-10-23 | Univ California | Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung |
US6752993B1 (en) | 1993-11-23 | 2004-06-22 | The Regents Of The University Of California | Abundant extracellular product vaccines and methods for their production and use |
WO1996005223A1 (en) * | 1994-08-12 | 1996-02-22 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5935568A (en) * | 1995-05-18 | 1999-08-10 | National Jewish Medical & Research Center | Gene therapy for effector cell regulation |
AU6260796A (en) * | 1995-06-07 | 1996-12-30 | National Jewish Center For Immunology And Respiratory Medicine | Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6290969B1 (en) | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
US6338852B1 (en) | 1995-09-01 | 2002-01-15 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
US6013660A (en) * | 1996-10-02 | 2000-01-11 | The Regents Of The University Of California | Externally targeted prophylactic and chemotherapeutic method and agents |
US6982085B2 (en) | 1997-04-02 | 2006-01-03 | Statens Serum Institut | TB diagnostic based on antigens from M. tuberculosis |
US7037510B2 (en) | 1997-04-18 | 2006-05-02 | Statens Serum Institut | Hybrids of M. tuberculosis antigens |
GB9714242D0 (en) * | 1997-07-07 | 1997-09-10 | Mini Agriculture & Fisheries | Glycosylation peptides |
US6291190B1 (en) * | 1998-08-25 | 2001-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular differences between species of the M. tuberculosis complex |
US6465633B1 (en) | 1998-12-24 | 2002-10-15 | Corixa Corporation | Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis |
AU5294000A (en) * | 1999-05-28 | 2000-12-18 | Promega Corporation | Antibodies specific for mycobacterial polypeptides and uses thereof |
GB0006693D0 (en) * | 2000-03-20 | 2000-05-10 | Glaxo Group Ltd | Vaccine |
US7288261B2 (en) * | 2000-07-10 | 2007-10-30 | Colorado State University Research Foundation | Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
US20050267025A1 (en) * | 2002-02-01 | 2005-12-01 | Ho John L | Compositions and methods for treatment of infectious and inflammatory diseases |
WO2003063798A2 (en) * | 2002-02-01 | 2003-08-07 | Cornell Research Foundation, Inc. | Compositions and methods for treatment of infectious and inflammatory diseases |
SG159554A1 (en) | 2004-11-16 | 2010-03-30 | Crucell Holland Bv | Multivalent vaccines comprising recombinant viral vectors |
US20120321656A1 (en) * | 2011-06-20 | 2012-12-20 | Matthias Rath | Oligopeptides and their use for treating infectious diseases |
WO2013090897A1 (en) * | 2011-12-15 | 2013-06-20 | The Trustees Of The University Of Pennsylvania | Using adaptive immunity to detect drug resistance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264550A (en) * | 1985-04-15 | 1993-11-23 | Scios Nova Inc. | Human anti-inflammatory phospholipase inhibitor protein |
US4689397A (en) * | 1985-08-12 | 1987-08-25 | Scripps Clinic And Research Foundation | Synthetic polypeptides for detecting mycobacterial infections |
EP0486495A1 (en) * | 1989-03-08 | 1992-05-27 | Commonwealth Scientific And Industrial Research Organisation | Expression system for actinomycetes and related organisms |
FR2645878B1 (fr) * | 1989-04-17 | 1994-02-25 | Institut Nal Sante Recherc Medic | Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes |
-
1991
- 1991-02-14 EP EP91400388A patent/EP0499003A1/en not_active Withdrawn
-
1992
- 1992-02-07 US US08/107,676 patent/US5955356A/en not_active Expired - Fee Related
- 1992-02-07 CA CA002104111A patent/CA2104111C/en not_active Expired - Fee Related
- 1992-02-07 EP EP92903939A patent/EP0571420B2/en not_active Expired - Lifetime
- 1992-02-07 WO PCT/EP1992/000268 patent/WO1992014823A1/en active IP Right Grant
- 1992-02-07 ES ES92903939T patent/ES2103928T5/es not_active Expired - Lifetime
- 1992-02-07 AT AT92903939T patent/ATE153697T1/de not_active IP Right Cessation
- 1992-02-07 DK DK92903939T patent/DK0571420T4/da active
- 1992-02-07 AU AU12234/92A patent/AU659822B2/en not_active Ceased
- 1992-02-07 JP JP4503952A patent/JPH06504909A/ja active Pending
- 1992-02-07 DE DE69220042T patent/DE69220042T3/de not_active Expired - Fee Related
- 1992-02-13 IL IL100938A patent/IL100938A0/xx unknown
-
1997
- 1997-08-11 GR GR970402052T patent/GR3024408T3/el unknown
-
1999
- 1999-04-21 US US09/295,820 patent/US6638511B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06504909A (ja) | 1994-06-09 |
DE69220042T3 (de) | 2005-12-01 |
DK0571420T3 (da) | 1997-12-29 |
EP0571420A1 (en) | 1993-12-01 |
WO1992014823A1 (en) | 1992-09-03 |
EP0499003A1 (en) | 1992-08-19 |
DE69220042T2 (de) | 1997-12-11 |
DE69220042D1 (de) | 1997-07-03 |
ES2103928T3 (es) | 1997-10-01 |
EP0571420B2 (en) | 2005-03-16 |
DK0571420T4 (da) | 2005-06-20 |
GR3024408T3 (en) | 1997-11-28 |
ATE153697T1 (de) | 1997-06-15 |
US5955356A (en) | 1999-09-21 |
CA2104111C (en) | 2008-01-08 |
CA2104111A1 (en) | 1992-08-15 |
US6638511B1 (en) | 2003-10-28 |
IL100938A0 (en) | 1992-11-15 |
EP0571420B1 (en) | 1997-05-28 |
AU1223492A (en) | 1992-09-15 |
AU659822B2 (en) | 1995-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2103928T5 (es) | Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis. | |
ES2058892T3 (es) | Uso de omeprazol como agente antimicrobiano. | |
ES2095355T3 (es) | Material transparente para usos dentales. | |
FI892131A (fi) | Analoger till underenheter av bordetellatoxin, vilka haerstammar fraon hybrid-dna. | |
AR017819A1 (es) | Sales de metformina, las composiciones farmaceuticas que las contienen, los metodos terapeuticos que aplican dichos compuestos y las combinaciones de talescompuestos con otros agentes terapeuticos | |
BR9910643A (pt) | Processos e produtos para a indução de imunidadede mucosa | |
PT92838A (pt) | Dispensing devices powered by hydrogel | |
IT8819158A0 (it) | Riscaldatore perfezionato da usare come sorgente di calore primaria o ausiliaria e circuiteria perfezionata per il controllo del riscaldatore. | |
NL300187I1 (nl) | Acellulair vaccin. | |
ES2144394T3 (es) | Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis. | |
DK55088A (da) | 3,4-dihydro-2h-benzo(b)pyraner, deres fremstilling og anvendelse som laegemidler | |
ES2069742T3 (es) | Proteina de la capsida del calicivirus felino y secuencia nucleotida. | |
NO890187D0 (no) | 2-(3,4-dihydroksyfenyl)etylaminer, deres fremstilling og anvendelse som farmasoeytika. | |
ES2093872T3 (es) | Procedimiento para la reactivacion de un catalizador de carbon activo empleado para la preparacion de 1,1,1,2,3,3,3-heptafluoropropano (r 227). | |
FI894650A (fi) | Antigen, som associerar till en human tumoer. | |
IT1223579B (it) | Clonaggio e sequenziamento del gene codificante per una nuova subunita' pilinica di bordetella pertussis | |
NO865055L (no) | Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse som overflateaktive midler, samt deres forloepere. | |
ES2171838T3 (es) | Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar. | |
ES2048599T5 (es) | Agente para el moldeado de cabellos humanos y empleo de clorofila y derivados de clorofila en agentes de este tipo. | |
ES2072865T3 (es) | Cepa bacteriana. | |
FI922864A0 (fi) | Terapeutiskt aktiva fluorsubsti- tuerade bensimidazoler, foerfaranden foer deras framstaellning samt deras anvaendning. | |
ES2032862T3 (es) | Una secuencia nucleotida capaz de inducir altos niveles de translacion de un gen heterologo en bacillus subtilis y escherichia coli. | |
IT1262196B (it) | Sistema scarpa/stivaletto con elemento di suola di rapida sostituzione | |
MX9203784A (es) | Composiciones para el tratamiento de osteoporosis en seres humanos. | |
ES555466A0 (es) | Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 571420 Country of ref document: ES |